The
Latest
The Latest
News
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
News
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
News
Filament Health Is Issued Second Patent By United States Patent And Trademark Office And Reports Q1 Results
News
Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment
More Articles
FEATURED
Aaron Bartlone, Chief Operating Officer | Cybin
News
HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil
News
PsyBio Therapeutics Develops Commercial Purification Process for Second Generation Psycho-Targeted Compound
Trending
#
Spotlight
Daniel Carcillo | Founder and CEO, Wesana Health
#
Spotlight
Aaron Bartlone, Chief Operating Officer | Cybin
#
Spotlight
Dr. Albert Garcia-Romeu | Johns Hopkins University School of Medicine
#
News
MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders
#
News
Wellbeing Digital Sciences Provides Commercial and Corporate Updates for KGK Science
Companies
#
Cybin Inc.
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Numinus
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Mind Medicine (MindMed)
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Wesana Health
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Tryp Therapeutics
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
Features
News
Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry
News
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
News
Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer
Spotlight
Aaron Bartlone, Chief Operating Officer | Cybin
© year Psychedelic Finance